Tasty THC: Promises and Challenges of Cannabis Edibles

scientific article published on 01 November 2016

Tasty THC: Promises and Challenges of Cannabis Edibles is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3768/RTIPRESS.2016.OP.0035.1611
P932PMC publication ID5260817
P698PubMed publication ID28127591

P50authorJenny L. WileyQ42407062
P2093author name stringNicholas C Peiper
Scott P Novak
Timothy W Lefever
Sheryl C Cates
Camille K Gourdet
Daniel G Barrus
Kristen L Capogrossi
P2860cites workTwo cases of "cannabis acute psychosis" following the administration of oral cannabisQ21260289
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapyQ24187798
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effectsQ24606148
Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THCQ24634909
Human cannabinoid pharmacokineticsQ24652736
Adverse health effects of marijuana useQ26861513
The toxicology of cannabis and cannabis prohibitionQ28241637
Literacy and misunderstanding prescription drug labelsQ28276402
Patient Understanding of Food LabelsQ29299881
Cannabinoids for Medical UseQ29391539
The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for PsychosisQ30047193
The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for painQ33578856
Cancer cachexia and cannabinoidsQ33781037
Smoked marijuana as a cause of lung injuryQ33989654
Pharmacokinetics and pharmacodynamics of cannabinoidsQ34185013
Cannabinoid hyperemesis syndromeQ34239091
Do Plasma Concentrations of Δ9-Tetrahydrocannabinol Reflect the Degree of Intoxication?Q51255437
Barriers and facilitators to cannabis treatment.Q51801858
Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuanaQ52264943
Marijuana-laced brownies: behavioral effects, physiologic effects, and urinalysis in humans following ingestion.Q52267219
Notes from the Field: Death Following Ingestion of an Edible Marijuana Product--Colorado, March 2014.Q53946966
Issues in the implementation and evolution of the commercial recreational cannabis market in ColoradoQ57841797
A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis useQ59488270
How well do consumers understand percentage daily value on food labels?Q73729229
Edible Cannabis-Induced Psychosis: Intoxication and BeyondQ86042345
Half-baked--the retail promotion of marijuana ediblesQ86904589
Characterization of edible marijuana product exposures reported to United States poison centersQ39600424
Smoking, vaping, eating: Is legalization impacting the way people use cannabis?Q39907915
Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinolQ39948828
Trends in registered medical marijuana participation across 13 US states and District of Columbia.Q40190400
Systematic Review of the Use of Phytochemicals for Management of Pain in Cancer Therapy.Q40313345
Change in perceived risk associated with marijuana use in the United States from 2002 to 2012.Q41487523
Inadvertent ingestion of marijuana - Los Angeles, California, 2009.Q43281031
Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humansQ44233097
Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokersQ44332720
Characterization of the absorption phase of marijuana smokingQ44377491
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis ProductsQ44669607
Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and moodQ46391618
Abuse potential of dronabinol (Marinol).Q46392742
THC can be detected in brain while absent in bloodQ46852374
Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in los angelesQ46886354
Self-Medication of Somatic and Psychiatric Conditions Using Botanical Marijuana.Q47916065
Cannabis with high cannabidiol content is associated with fewer psychotic experiencesQ48868841
Blurred boundaries: the therapeutics and politics of medical marijuanaQ34251969
Evaluation of trends in marijuana toxicosis in dogs living in a state with legalized medical marijuana: 125 dogs (2005-2010).Q34315874
The pharmacologic and clinical effects of medical cannabis.Q34326515
Marijuana use and risk of lung cancer: a 40-year cohort studyQ34356964
Epidemiologic review of marijuana use and cancer riskQ34438543
Adverse effects of cannabisQ34482452
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder.Q34486089
Cannabinoids in the Treatment of EpilepsyQ34493353
Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleepQ34641364
Impact of Cannabis Use on the Development of Psychotic DisordersQ34668606
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?Q34676610
A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditionsQ34722366
Stigma among California's Medical Marijuana PatientsQ35124951
The implications of marijuana legalization in ColoradoQ35500385
Psychiatric and medical management of marijuana intoxication in the emergency departmentQ35592725
Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependenceQ35651468
Trends in use of marijuana and attitudes toward marijuana among youth before and after decriminalization: the case of California 2007-2013.Q35748033
Consumer understanding and use of nutrition labelling: a systematic reviewQ36037621
Long term marijuana users seeking medical cannabis in California (2001-2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicantsQ36329247
Towards the use of non-psychoactive cannabinoids for prostate cancerQ36603185
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive studyQ36647069
Teen Use of Marijuana Edibles: A Focus Group Study of an Emerging IssueQ36892724
Marijuana Tourism and Emergency Department Visits in ColoradoQ36930033
Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa.Q36936213
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked CannabisQ37006281
Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokersQ37103395
Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013.Q37285983
Chronic toxicology of cannabisQ37544803
In the weeds: a baseline view of cannabis use among legalizing states and their neighboursQ37562364
Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicineQ37871980
Association of unintentional pediatric exposures with decriminalization of marijuana in the United StatesQ38186173
Toking, Vaping, and Eating for Health or Fun: Marijuana Use Patterns in Adults, U.S., 2014.Q38546980
A global toxicogenomic analysis investigating the mechanistic differences between tobacco and marijuana smoke condensates in vitro.Q39173338
Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.Q39219604
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P577publication date2016-11-01
P1476titleTasty THC: Promises and Challenges of Cannabis Edibles
P478volume2016

Reverse relations

cites work (P2860)
Q52646288Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods.
Q64232401Age-related differences in the impact of cannabis use on the brain and cognition: a systematic review
Q90626055Cannabis and mental illness: a review
Q88907845Cannabis regulatory science: risk-benefit considerations for mental disorders
Q57300431Comparison of the locations where young adults smoke, vape, and eat/drink cannabis: Implications for harm reduction
Q89652292Complex cannabis use patterns: Associations with cannabis consequences and cannabis use disorder symptomatology
Q54525669Evaluation of reinforcing and aversive effects of voluntary Δ9-tetrahydrocannabinol ingestion in rats.
Q92452522Health considerations of the legalization of cannabis edibles
Q90115713Insights into the role of cannabis in the management of inflammatory bowel disease
Q92709700Joint and separate exposure to alcohol and ∆9-tetrahydrocannabinol produced distinct effects on glucose and insulin homeostasis in male rats
Q47658270Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing relationship?
Q92169824Marijuana Use in Pregnancy: A Review
Q99413706Pharmacokinetic, behavioral, and brain activity effects of Δ9-tetrahydrocannabinol in adolescent male and female rats
Q50041116Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control.
Q64130865Syndromic Surveillance of Emergency Department Visits for Acute Adverse Effects of Marijuana, Tri-County Health Department, Colorado, 2016-2017
Q92972277Voluntary oral consumption of Δ9-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood